Fat grafting for treatment of burns, burn scars, and other difficult wounds.
Nelson Sarto Piccolo, Mônica Sarto Piccolo, Maria Thereza Sarto Piccolo
https://pubmed.ncbi.nlm.nih.gov/25827568/Actively Recruiting
Led by University of Pittsburgh · Updated on 2026-07-22
40
Participants Needed
2
Research Sites
39 weeks
Total Duration
This research aims to evaluate if an adipose-based therapeutic strategy can effectively treat contracted scars caused by soft-tissue burn wounds or trauma, particularly in individuals with severe burns or tissue loss. The study focuses on comparing autologous layered composite grafting to traditional full-thickness skin grafting for delayed reconstruction of scar contractures after burns or trauma. The goal is to see whether the fat-based method can match or outperform standard treatments in healing, reducing scarring, and lowering infection risk. Participants will be randomly assigned to one of two groups. One group will receive the traditional full-thickness skin graft FTSG following standard scar release and wound bed preparation. The other group will undergo autologous layered composite grafting, which involves harvesting fat through minimally invasive liposuction and applying it directly to the wound base, followed by a split-thickness skin graft placed over the fat layer. Both treatments are delivered in a single-stage surgery for reconstruction of defects in the face, neck, or extremities. During the study, participants will be monitored from the time of surgery through a 9-month follow-up. Researchers will assess changes in scar contracture by measuring scar surface area and evaluate safety through the incidence of treatment-related adverse events. Additional assessments will include scar quality using the Patient and Observer Scar Assessment Scale, graft success, healing time, tissue thickness, pliability, and mobility. The study aims to provide detailed information on healing outcomes and graft effectiveness over this period.
CONDITIONS
Autologous Point-of-Care Adipose Therapy: Delayed Injury/Scar
E
Eleanor Shirley
P
Patsy Simon
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Pittsburgh
Lead Sponsor
Armed Forces Institute of Regenerative Medicine
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Autologous Layered Composite Grafting (Fat + STSG) | Full Thickness Skin Graft (FTSG) |
|---|---|---|
| What it is | A surgical procedure combining autologous fat grafting to the wound base followed by a split thickness skin graft layered on top, with fat harvested from the patient by liposuction and applied directly without chemical or biological processing. | Surgical transfer of a full-thickness piece of skin, typically from a hidden or non-cosmetic donor area, excised with overlying fat removed before grafting to the reconstruction site. |
| Role in trial | Tested as the investigational approach for improving outcomes after contracture scar release. | Serves as the control arm, reflecting established reconstructive practice following contracture release. |
| Primary use in care | Used for surgical reconstruction after contracture scar release, aiming to improve scarring and functional outcome by providing added volume and support beneath the skin graft. | Frequently performed to reconstruct defects after scar contracture release, particularly where skin quality or cosmetic match is important. |
| How it is given or performed | Fat is collected by minimally invasive liposuction from the patient, then layered onto the wound base before a split thickness skin graft is applied over the top, all in a single surgical stage. | A full-thickness skin graft is harvested by excising skin from a matched donor area, removing deeper fat and soft tissues, then transplanted to cover the reconstruction site; donor site is closed surgically. |
| Evidence status | There is some published evidence supporting autologous fat grafting to improve difficult burn and scar wounds, but evidence for its use beneath split thickness skin grafts in contracture scar reconstruction remains limited and is being directly studied in this trial. | Full thickness skin grafting has established efficacy in reconstructive surgery after contracture release, with data supporting its use in restoring skin coverage and improving function in challenging wounds. |
| Important limitations | Evidence for the layered fat plus split skin graft approach is largely limited to small case series and individual reports, with limited long-term outcome data and potential variability in fat uptake and integration. | Potential for donor site morbidity, risk of contracture recurrence, and possible suboptimal color and texture match; experience and technique can affect results. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single-stage procedure at time of scar revision
Participants receive either a full-thickness skin graft or autologous layered composite graft involving fat and split-thickness skin grafts for scar reconstruction after burn or trauma revision.
1 surgery visit and follow-up assessments
Duration - 9 months
Participants are monitored for up to 9 months after surgery to assess scar healing, graft success, and safety through clinical evaluations and scar assessments.
Periodic follow-up visits
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Nelson Sarto Piccolo, Mônica Sarto Piccolo, Maria Thereza Sarto Piccolo
https://pubmed.ncbi.nlm.nih.gov/25827568/Celeste C Finnerty, Marc G Jeschke, Ludwik K Branski...
https://pubmed.ncbi.nlm.nih.gov/27707499/Francesco Simonacci, Nicolò Bertozzi, Michele Pio Grieco...
https://pubmed.ncbi.nlm.nih.gov/28702187/Clement D Marshall, Michael S Hu, Tripp Leavitt...
https://pubmed.ncbi.nlm.nih.gov/29392092/Susan I Woodruff, Michael R Galarneau, Cameron T McCabe...
https://pubmed.ncbi.nlm.nih.gov/29450855/Brogan G A Evans, Edward M Gronet, Michel H Saint-Cyr
https://pubmed.ncbi.nlm.nih.gov/32802628/Tuan D Le, Jennifer M Gurney, Nina S Nnamani...
https://pubmed.ncbi.nlm.nih.gov/29847675/Edwin W D'Souza, Andrew J MacGregor, Amber L Dougherty...
https://pubmed.ncbi.nlm.nih.gov/35385552/Bridget L Harrison, Chrisovalantis Lakhiani, Michael R Lee...
https://pubmed.ncbi.nlm.nih.gov/23676968/Zrinka Bukvić Mokos, Anamaria Jović, Lovorka Grgurević...
https://pubmed.ncbi.nlm.nih.gov/28676850/University of Pittsburgh
Lead Sponsor
Armed Forces Institute of Regenerative Medicine
Collaborating Sponsor